Summing it up

Molnupiravir accounts for largest share of Covid-19 oral antiviral market, government expenditure: drug utilisation committee Molnupiravir (Lagevrio) is the most popular Covid-19 antiviral of choice, according to new data published on Friday. It also accounted for the highest government expenditure on medicines in 2022-23. In 2022, 448,358 patients were supplied 466,598 molnupiravir prescriptions, the Drug